Works matching IS 14611457 AND DT 2005 AND VI 8 AND IP 2

Results: 20

The metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 153, doi. 10.1017/s1461145705005183

By:

Herbert Y. Meltzer

Publication type:

Article

Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 203, doi. 10.1017/s1461145704005036

By:

Bankole A. Johnson;
John D. Roache;
Nassima Ait-Daoud;
Christopher Wallace;
Lynda Wells;
Michael Dawes;
Yanmei Wang

Publication type:

Article

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 183, doi. 10.1017/s1461145705005110

By:

Robert C. Smith;
Jean-Pierre Lindenmayer;
Nigel Bark;
Jessy Warner-Cohen;
Sumathi Vaidhyanathaswamy;
Amaresh Khandat

Publication type:

Article

A case of delayed galactorrhoea as an adverse event of overlapping haloperidol and clozapine administration.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 303, doi. 10.1017/s1461145705005109

By:

Andreas Conca;
Manfred Waler;
Michaela Walpoth;
Peter Knig;
Armand Hausmann

Publication type:

Article

Associations between serotonin-related gene polymorphisms and panic disorder.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 261, doi. 10.1017/s1461145704004985

By:

Eduard Maron;
Aavo Lang;
Gunnar Tasa;
Liivi Liivlaid;
Innar Tru;
Anne Must;
Veiko Vasar;
Jakov Shlik

Publication type:

Article

Effects of quetiapine and haloperidol on body mass index and glycaemic control: a long-term, randomized, controlled trial.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 175, doi. 10.1017/s1461145705005067

By:

Robin Emsley;
H. Jadri Turner;
Juan Schronen;
Karien Botha;
Retha Smit;
Piet P. Oosthuizen

Publication type:

Article

Focus on The clinical ramifications of antipsychotic choice for the risk for developing type 2 diabetes mellitus.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 147, doi. 10.1017/s1461145705005171

By:

Leslie Citrome

Publication type:

Article

Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 195, doi. 10.1017/s1461145704005012

By:

Martin Dossenbach;
Andrew Hodge;
Martin Anders;
Bla Molnr;
Dalia Peciukaitiene;
Irena Krupka-Matuszczyk;
Mihai Tatu;
Victor Bondar;
Jan Pecenak;
Tatjana Gorjanc;
Margaret McBride

Publication type:

Article

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 267, doi. 10.1017/s1461145704004997

By:

Manit Srisurapanont;
Ngamwong Jarusuraisin

Publication type:

Article

Rapid cycling bipolar disorder: biology and pathogenesis.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 281, doi. 10.1017/s1461145705005092

By:

George N. Papadimitriou;
Joseph R. Calabrese;
Dimitris G. Dikeos;
George N. Christodoulou

Publication type:

Article

Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 245, doi. 10.1017/s1461145704004900

By:

Chima Matsumoto;
Takahiro Shinkai;
Vincenzo De Luca;
Rudi Hwang;
Hiroko Hori;
Matthew Lanktree;
Osamu Ohmori;
James L. Kennedy;
Jun Nakamura

Publication type:

Article

Zopiclone dependence after insomnia related to torticollis.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 309, doi. 10.1017/s1461145704004973

By:

Christian Haasen;
Tomas Mueller-Thomsen;
Torsten Fink;
Alexandra Bussopulos;
Jens Reimer

Publication type:

Article

Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 223, doi. 10.1017/s1461145704004912

By:

Andrei V. Chistyakov;
Boris Kaplan;
Odil Rubichek;
Isabella Kreinin;
Dany Koren;
Moshe Feinsod;
Ehud Klein

Publication type:

Article

Low doses of lithium carbonate reduce melatonin light sensitivity in healthy volunteers.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 255, doi. 10.1017/s1461145704004894

By:

Karen T. Hallam;
James S. Olver;
Jennifer E. Horgan;
Caroline McGrath;
Trevor R. Norman

Publication type:

Article

Treatment of Raynaud's phenomenon with escitalopram.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 307, doi. 10.1017/s1461145704004882

By:

Ansgar Buecking;
Estelle Rougemont;
Daniele Fabio Zullino

Publication type:

Article

Evidence-based pharmacotherapy of Generalized Anxiety Disorder.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 293, doi. 10.1017/s1461145704004870

By:

David S. Baldwin;
Claire Polkinghorn

Publication type:

Article

Exposure to juvenile stress exacerbates the behavioural consequences of exposure to stress in the adult rat.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 163, doi. 10.1017/s1461145704004808

By:

Avi Avital;
Gal Richter-Levin

Publication type:

Article

The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 157, doi. 10.1017/s1461145704004742

By:

Kent Jardemark;
Monica M. Marcus;
sa Konradsson;
Torgny H. Svensson

Publication type:

Article

Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 235, doi. 10.1017/s1461145704004791

By:

Kati Koido;
Sulev Kks;
Tiit Nikopensius;
Eduard Maron;
Signe Altme;
Evelin Heinaste;
Kristel Vabrit;
Veronika Tammekivi;
Pille Hallast;
Ants Kurg;
Jakov Shlik;
Veiko Vasar;
Andres Metspalu;
Eero Vasar

Publication type:

Article

Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 2, p. 215, doi. 10.1017/s1461145704004717

By:

Harald Murck;
Maurizio Fava;
Jonathan Alpert;
Andrew A. Nierenberg;
David Mischoulon;
Michael W. Otto;
John Zajecka;
Marcus Mannel;
Jerrold F. Rosenbaum

Publication type:

Article